Esperto Francesco, Cacciatore Loris, Tedesco Francesco, Testa Antonio, Callè Pasquale, Ragusa Alberto, Deanesi Noemi, Minore Antonio, Prata Francesco, Brassetti Aldo, Papalia Rocco, Scarpa Roberto Mario
Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, 00128 Rome, Italy.
Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.
J Pers Med. 2023 May 5;13(5):794. doi: 10.3390/jpm13050794.
Prostate cancer (PCa) surgery has a strong impact on men's social and sexual lives. For this reason, many patients ask for robotic surgery. To assess the rate of lost patients due to the lack of a robotic platform (RPl) at our center, we retrospectively selected 577 patients who underwent prostate biopsy between 2020 and 2021 who were eligible for radical prostatectomy (RP) (ISUP ≥ 2; age ≤ 70 yr). Patients eligible for surgery who decided to be operated received a phone call interview asking the reason for their choice. Overall, 230 patients (31.7%) underwent laparoscopic-assisted radical prostatectomy (LaRP) at our center, while 494 patients (68.3%) were not treated in our hospital. Finally, 347 patients were included: 87 patients (25.1%) underwent radiotherapy; 59 patients (17%) were already under another urologist's care; 113 patients (32.5%) underwent robotic surgery elsewhere; and 88 patients (25.4%) followed the suggestion of friends or relatives based on their surgical experience. Despite no surgical technique for RP having shown superiority in terms of oncological or functional outcomes, patients eligible for PCa treatment decided to be operated on elsewhere because of the lack of an RPl. Our results show how the presence of an RPl may increase the case volume of RP by 49% at our center.
前列腺癌（PCa）手术对男性的社交和性生活有重大影响。因此，许多患者要求进行机器人手术。为了评估由于我们中心缺乏机器人平台（RP1）而导致的患者流失率，我们回顾性选择了2020年至2021年间接受前列腺活检且符合根治性前列腺切除术（RP）条件的577例患者（国际泌尿病理学会[ISUP]≥2；年龄≤70岁）。决定接受手术的符合手术条件的患者接受了电话访谈，询问他们选择的原因。总体而言，230例患者（31.7%）在我们中心接受了腹腔镜辅助根治性前列腺切除术（LaRP），而494例患者（68.3%）未在我们医院接受治疗。最后，纳入了347例患者：87例患者（25.1%）接受了放疗；59例患者（17%）已在另一位泌尿科医生的治疗下；113例患者（32.5%）在其他地方接受了机器人手术；88例患者（25.4%）根据朋友或亲属的手术经验听从了他们的建议。尽管没有一种RP手术技术在肿瘤学或功能结果方面显示出优越性，但符合PCa治疗条件的患者因缺乏RP1而决定在其他地方接受手术。我们的结果表明，RP1的存在可能会使我们中心的RP病例量增加49%。
